Overview

Drug Drug Interaction Study Evaluating the Effect of Fluvoxamine or Fluconazole on PK and Safety of PF-04965842.

Status:
Completed
Trial end date:
2018-12-13
Target enrollment:
Participant gender:
Summary
A Phase 1, Open Label, Parallel-Cohort, Randomized, Fixed Sequence Study To Evaluate The Pharmacokinetic Drug Drug Interaction Between PF-04965842 and Fkuvoxamine (cohort 1) or Fluconazole (Cohort 2) in healthy subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer
Treatments:
Abrocitinib
Fluconazole
Fluvoxamine